Skip to main content
SpringerLink
Log in

Bevacizumab

Various toxicities: 7 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ashinuma H, et al. Safety and efficacy of bevacizumab-containing chemotherapy in NSCLC patients with brain metastases. Annals of Oncology 25 (Suppl. 5): v96 abstr. P2-18-2, Oct 2014. Available from: URL: http://doi.org/10.1093/annonc/mdu436.95 [abstract] - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bevacizumab. Reactions Weekly 1543, 48 (2015). https://doi.org/10.1007/s40278-015-8672-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-8672-7

Search

Navigation